Back to NMRA
Exor N.V. NMRA Position History
Neumora Therapeutics, Inc. • Healthcare
Quarters held
13
Latest value
$2.5M
Q3 2026
Peak value
$71.9M
First seen
Q3 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2023 | $59.5M |
| Q4 2023 | $71.9M |
| Q1 2024 | $58M |
| Q2 2024 | $41.4M |
| Q3 2024 | $55.7M |
| Q4 2024 | $44.7M |
| Q1 2025 | $4.2M |
| Q2 2025 | $3.1M |
| Q3 2025 | $7.7M |
| Q4 2025 | $7.5M |
| Q1 2026 | $8.2M |
| Q2 2026 | $7.2M |
| Q3 2026 | $2.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2.5M | 4.22M | — | — |
| Q2 2026 | $7.2M | 4.22M | — | — |
| Q1 2026 | $8.2M | 4.22M | — | — |
| Q4 2025 | $7.5M | 4.22M | — | — |
| Q3 2025 | $7.7M | 4.22M | — | — |
| Q2 2025 | $3.1M | 4.22M | — | — |
| Q1 2025 | $4.2M | 4.22M | — | — |
| Q4 2024 | $44.7M | 4.22M | — | — |
| Q3 2024 | $55.7M | 4.22M | — | — |
| Q2 2024 | $41.4M | 4.22M | — | — |
| Q1 2024 | $58M | 4.22M | — | — |
| Q4 2023 | $71.9M | 4.22M | — | — |
| Q3 2023 | $59.5M | 4.22M | — | — |